泌尿肿瘤手术医生特异性 episode 费用的稳定性:对 MIPS 下泌尿外科医生的启示
该研究基于 SEER-Medicare 数据,分析 2008–2012 年 1895 名医生完成的 14585 例前列腺切除术、肾切除术和膀胱切除术的 90 天 episode 费用。结果显示医生间费用差异大,但医生费用分层随时间及跨术式不稳定,对 MIPS 成本指标能否可靠区分低效或低质量医疗提出质疑。
要点
- 泌尿肿瘤手术医生间 90 天 episode 费用差异显著。
- 医生费用分层年际稳定性差,跨术式相关性极低。
- MIPS 成本指标可能难以可靠识别低效或低质量医生。
核心结论
- 前列腺切除术、肾切除术和膀胱切除术的医生特异性 episode 费用差异大。
- 医生费用模式随时间及跨术式不稳定,对 MIPS 成本指标改变医生行为及可靠区分低效或低质量医疗的能力提出担忧。
研究设计与样本
- 利用 SEER-Medicare 数据识别 2008–2012 年接受前列腺切除术、肾切除术或膀胱切除术的 66–99 岁患者。
- 共纳入 14585 例患者,由 1895 名 unique 临床医生完成手术。
- 计算每名外科医生每种术式的平均 90 天 episode 支付费用。
主要发现
- 最高与最低 quartile 医生间支付差异:前列腺切除术 5881 美元,肾切除术 17714 美元,膀胱切除术 40288 美元。
- 2010 年最高支出 quartile 医生中,2011 年仍处于最高 quartile 的比例:前列腺切除术 39%,肾切除术 16%,膀胱切除术 13%。
- 外科医生跨术式支出相关性极小。
临床怎么用
- 临床解读 MIPS 成本指标时应考虑医生费用模式的不稳定性及跨术式差异。
- 不宜仅凭单一年度或单一术式的 episode 费用判断医生效率或质量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the stability of physician-specific episode payments for prostatectomy, nephrectomy, and cystectomy in the context of value-based purchasing programs, such as the merit-based incentive payment system. METHODS: We utilized Surveillance, Epidemiology and End Results-Medicare data to identify patients aged 66-99 who underwent a prostatectomy, nephrectomy, or cystectomy from 2008 to 2012. We calculated each surgeon's average 90-day episode payment by procedure. Next, we examined payment differences between the most and least expensive quartile providers. For the most expensive quartile of physicians in 2010, we examined their spending quartile in 2011. Finally, we evaluated the correlation in spending over time and across procedures. RESULTS: We identified 14,585 patients who underwent surgery by one of 1895 unique clinicians. Differences in payments between the highest and lowest quartiles were $5881, $17,714, and $40,288 for prostatectomy, nephrectomy, and cystectomy, respectively. Only 39%, 16%, and 13% of physicians that were in the highest spending quartile for prostatectomy, nephrectomy, and cystectomy in 2010 were also in the most expensive quartile in 2011. Although we observed weak correlation in year-to-year spending for prostatectomy (0.108, P = .033 to .270, P < .001), annual payments for nephrectomy and cystectomy were not significantly correlated. Finally, there was minimal correlation in surgeon spending across procedures. CONCLUSION: There is wide variation in physician-specific episode payments for prostatectomy, nephrectomy, and cystectomy. However, physician spending patterns are not stable over time or across procedures, raising concerns about the ability of the cost-based measures in merit-based incentive payment system to change physician behavior and reliably distinguish those providing less efficient or lower quality care.
引用
- Kaye DR, Ye Z, Li J, et al. The Stability of Physician-Specific Episode Costs for Urologic Cancer Surgery: Implications for Urologists Under the Merit-Based Incentive Program. Urology. 2018. PMID: 30125647. doi:10.1016/j.urology.2018.04.051
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。